Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 01 Sept 2026 for Crinetics Pharmaceuticals, Inc., €1.2M.
Filing timeline
BuySaleCaren Deardorf
Insider track record
Disclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Caren Deardorf: trading record in brief
Caren Deardorf (senior executive) discloses dealings in 2 companies, chiefly Crinetics Pharmaceuticals, Inc. and Dianthus Therapeutics, Inc. /DE/. In total, 10 filings cover trades dated from 14 September 2021 to 1 September 2026.
Every open-market trade on record is a sale: 1 sale worth €36k. Other entries cover 7 share grants.
On 1 September 2026 came the latest disclosure, a transaction for €434k in Crinetics Pharmaceuticals, Inc. Typically, a trade is published a median of 4 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Caren Deardorf
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
16,300 shares@ US$85.000.015% mcap73.3% of flowCommon StockSEC:0001628280-26-059901:0
5,925 shares@ US$85.000.0056% mcap26.7% of flowCommon StockSEC:0001628280-26-059901:1
5,925 sharesCommon StockSEC:0001628280-26-044721:0
6,900 shares0Common StockSEC:0000950170-25-086269:0
3,400 shares0Common StockSEC:0000950170-24-071931:0
6,000 shares0Common StockSEC:0001209191-23-038823:0
3,000 shares@ US$0.943.6% of flowCommon StockSEC:0000899243-22-037432:0
3,000 shares@ US$0.996.7% of flowCommon StockSEC:0000899243-22-021185:0
6,238 shares@ US$6.7386.6% of flowCommon StockSEC:0000899243-21-036600:0
20,000 shares0Common StockSEC:0000899243-21-036338:0
10 of 10 declarations
